Login / Signup

Extraction of recombinant periplasmic proteins under industrially relevant process conditions: Selectivity and yield strongly depend on protein titer and methodology.

Clemens SchimekEsther EggerChristopher TauerGerald StriednerCécile BrocardMonika Cserjan-PuschmannRainer Hahn
Published in: Biotechnology progress (2020)
In this work, we attempted to identify a method for the selective extraction of periplasmic endogenously expressed proteins, which is applicable at an industrial scale. For this purpose, we used an expression model that allows coexpression of two fluorescent proteins, each of which is specifically targeted to either the cytoplasm or periplasm. We assessed a number of scalable lysis methods (high-pressure homogenization, osmotic shock procedures, extraction with ethylenediaminetetraacetic acid, and extraction with deoxycholate) for the ability to selectively extract periplasmic proteins rather than cytoplasmic proteins. Our main conclusion was that although we identified industrially scalable lysis conditions that significantly increased the starting purity for further purification, none of the tested conditions were selective for periplasmic protein over cytoplasmic protein. Furthermore, we demonstrated that efficient extraction of the expressed recombinant proteins was largely dependent on the overall protein concentration in the cell.
Keyphrases
  • protein protein
  • stem cells
  • amino acid
  • poor prognosis
  • cancer therapy
  • long non coding rna
  • risk assessment
  • quantum dots
  • cell therapy
  • mesenchymal stem cells
  • living cells
  • fluorescent probe